EuroPCR Wrap-Up: TAVI And TMVI From Edwards, St. Jude, Boston Scientific, Direct Flow, and Tendyne
This article was originally published in Clinica
EuroPCR is one of the most important annual conferences for interventional cardiology in the world, always showcasing potentially important new catheter-based technologies. Once again, data from clinical trials of transcatheter valves were a big part of this year’s event, held May 17-20 in Paris.
You may also be interested in...
EuroPCR 2018: Real-World TAVR Data Show Consistent Performance With Edwards, Abbott, And Medtronic's Systems
New real-world data on Edward Lifesciences real-world data for its transcatheter aortic valve replacement Sapien 3 valve are among the highlights from the early Hot Line/Late-Breaking Trial sessions at the EuroPCR conference in Paris.
Divesting the heart valve division will allow LivaNova to focus more resources on its neuromodulation, cardiopulmonary and circulatory support businesses.
The series D financing will support the expansion of Everlywell’s consumer lab testing and digital health businesses.